Canyilmaz Emine, Uslu Gonca Dilek Hanedan, Colak Fatma, Hazeral Burcin, Haciislamoglu Emel, Zengin Ahmet Yasar, Sari Ahmet, Yoney Adnan
Department of Radiation Oncology, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey.
Department of Radiation Oncology, Kanuni Research and Education Hospital, Trabzon, Turkey.
Springerplus. 2015 Mar 5;4:114. doi: 10.1186/s40064-015-0894-x. eCollection 2015.
The aim of this study was to assess the feasibility of sparing contralateral hippocampus during partial brain radiotherapy in high grade gliomas. 20 previously treated patients were replanned to 60 Gy in 30 fractions with sparing intensity-modulated radiotherapy (IMRT) and volumetric modulated arctherapy (VMAT) using the following planning objectives: 100 % of PTV covered by 95% isodose without violating organs at risk (OAR) and hot spot dose constraints. For each, standard intensity-modulated radiotherapy (IMRT) plans were generated, as well as sparing IMRT and VMAT plans which spared contralateral (hemispheric cases) hippocampus. When the three plans were compared, there was equivalent PTV coverage, homogeneity, and conformality. Sparing IMRT significantly reduced maximum, mean, V20, V30 and V40 hippocampus doses compared with standart IMRT and VMAT (p < 0.05). VMAT significantly reduced maximum left lens and mean eye doses compared with standart IMRT and sparing IMRT (p < 0.05). Brainstem, chiasm, left and right optic nerves, right eyes and lens doses were similar. VMAT significantly reduced monitor units compared with standart IMRT and sparing IMRT (p < 0.05). It is possible to spare contralateral hippocampus during PBRT for high grade gliomas using IMRT. This approach may reduce late cognitive sequelae of cranial radiotherapy.
本研究的目的是评估在高级别胶质瘤的部分脑放疗中保留对侧海马体的可行性。对20例先前接受过治疗的患者重新制定计划,采用以下计划目标,通过保留调强放疗(IMRT)和容积调强弧形放疗(VMAT)给予60 Gy分30次照射:100%的计划靶体积(PTV)被95%等剂量线覆盖,同时不违反危及器官(OAR)和热点剂量限制。对于每例患者,生成了标准调强放疗(IMRT)计划,以及保留对侧(半球病例)海马体的IMRT和VMAT计划。当比较这三种计划时,PTV覆盖率、均匀性和适形性相当。与标准IMRT和VMAT相比,保留IMRT显著降低了海马体的最大剂量、平均剂量、V20、V30和V40(p<0.05)。与标准IMRT和保留IMRT相比,VMAT显著降低了左晶状体的最大剂量和眼球的平均剂量(p<0.05)。脑干、视交叉、左右视神经、右眼和晶状体的剂量相似。与标准IMRT和保留IMRT相比,VMAT显著减少了监测单位(p<0.05)。使用IMRT在高级别胶质瘤的部分脑放疗期间保留对侧海马体是可行的。这种方法可能会减少颅脑放疗的晚期认知后遗症。